Preventing unintended pregnancy: The contraceptive CHOICE project in review

Journal of Women's Health

Volumn 24, Issue 5, 2015, Pages 349-353

  Birgisson, Natalia E ^a   Zhao, Qiuhong ^a   Secura, Gina M ^a   Madden, Tessa ^a   Peipert, Jeffrey F ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADOLESCENT PREGNANCY; ADULT; CHILDBIRTH; CLINICAL EFFECTIVENESS; COHORT ANALYSIS; CONTRACEPTION; CONTRACEPTIVE BEHAVIOR; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COPPER INTRAUTERINE DEVICE; COST CONTROL; DRUG IMPLANT; EDUCATIONAL STATUS; FEMALE; FEMALE CONTRACEPTIVE DEVICE; HEALTH CARE ACCESS; HEALTH CARE AVAILABILITY; HEALTH CARE COST; HEALTH CARE DISPARITY; HUMAN; LEVONORGESTREL RELEASING INTRAUTERINE SYSTEM; MAJOR CLINICAL STUDY; OUTCOME ASSESSMENT; PATIENT COUNSELING; PRIORITY JOURNAL; PROSPECTIVE STUDY; RECURRENT ABORTION; REVIEW; SUBDERMAL IMPLANT; UNITED STATES; UNPLANNED PREGNANCY; CLASSIFICATION; DECISION MAKING; DEVICE FAILURE; INDUCED ABORTION; INTRAUTERINE CONTRACEPTIVE DEVICE; MIDDLE AGED; MISSOURI; PREGNANCY; PREVENTION AND CONTROL; STATISTICS AND NUMERICAL DATA; YOUNG ADULT;

CONTRACEPTIVE AGENT; LEVONORGESTREL;

ABORTION, INDUCED; ADOLESCENT; ADULT; CHOICE BEHAVIOR; CONTRACEPTION; CONTRACEPTIVE AGENTS, FEMALE; EQUIPMENT FAILURE; FEMALE; HUMANS; INTRAUTERINE DEVICES; LEVONORGESTREL; MIDDLE AGED; MISSOURI; PREGNANCY; PREGNANCY IN ADOLESCENCE; PREGNANCY, UNPLANNED; PROSPECTIVE STUDIES; YOUNG ADULT;

EID: 84929409790     PISSN: 15409996     EISSN: 1931843X     Source Type: Journal    
DOI: 10.1089/jwh.2015.5191     Document Type: Review

References (23)

1. Finer LB, Zolna MR. Shifts in intended and unintended pregnancies in the United States, 2001-2008. Am J Public Health 2014;104:S43-48.
2. Luther NY, Thapa S, Westley SB. Nepal survey shows that "family planning saves lives." Asia Pac Pop Policy 1999; 49:1-4.
3. Sadik N. Reproductive health/family planning and the health of infants, girls and women. Indian J Pediatr 1997; 64:739-744.
4. Bernstein PS, Rosenfield A. Abortion and maternal health. Int J Gynaecol Obstet 1998;63:S115-S122.
5. Finer LB, Jerman J, Kavanaugh ML. Changes in use of long-acting contraceptive methods in the United States, 2007-2009. Fertil Steril 2012;98:893-897.
6. Stanwood NL, Garrett JM, Konrad TR. Obstetrician-gynecologists and the intrauterine device: A survey of attitudes and practice. Obstet Gynecol 2002;99:275-280.
7. Biggs MA, Harper CC, Malvin J, Brindis CD. Factors influencing the provision of long-acting reversible contraception in California. Obstet Gynecol 2014;123:593-602.
8. Kavanaugh ML, Jerman J, Ethier K, Moskosky S. Meeting the contraceptive needs of teens and young adults: Youthfriendly and long-acting reversible contraceptive services in U.S. family planning facilities. J Adolesc Health 2013; 52:284-292.
9. Kavanaugh ML, Frohwirth L, Jerman J, Popkin R, Ethier K. Long-acting reversible contraception for adolescents and young adults: Patient and provider perspectives. J Pediatr Adolesc Gynecol 2013;26:86-95.
10. Yu JM, Henderson JT, Harper CC, Sawaya GF. Obstetrician-gynecologists' beliefs on the importance of pelvic examinations in assessing hormonal contraception eligibility. Contraception 2014;90:612-614.
11. Madden T, Mullersman JL, Omvig KJ, Secura GM, Peipert JF. Structured contraceptive counseling provided by the Contraceptive CHOICE Project. Contraception 2013;88: 243-249.
12. Peipert JF, Madden T, Allsworth JE, Secura GM. Preventing unintended pregnancies by providing no-cost contraception. Obstet Gynecol 2012;120:1291-1297.
13. Rosenstock JR, Peipert JF, Madden T, Zhao Q, Secura GM. Continuation of reversible contraception in teenagers and young women. Obstet Gynecol 2012;120:1298-1305.
14. Secura GM, Madden T, McNicholas C, et al. Provision of no-cost, long-acting contraception and teenage pregnancy. New Engl J Med 2014;371:1316-1323.
15. O'Neil-Callahan M, Peipert JF, Zhao Q, Madden T, Secura G. Twenty-four-month continuation of reversible contraception. Obstet Gynecol 2013;122:1083-1091.
16. Grunloh DS, Casner T, Secura GM, Peipert JF, Madden T. Characteristics associated with discontinuation of longacting reversible contraception within the first 6 months of use. Obstet Gynecol 2013;122:1214-1221.
17. Secura GM, Adams T, Buckel CM, Zhao Q, Peipert JF. Change in sexual behavior with provision of no-cost contraception. Obstet Gynecol 2014;123:771-776.
18. Winner B, Peipert JF, Zhao Q, et al. Effectiveness of longacting reversible contraception. New Engl J Med 2012; 366:1998-2007.
19. Secura GM, Allsworth JE, Madden T, Mullersman JL, Peipert JF. The Contraceptive CHOICE Project: Reducing barriers to long-acting reversible contraception. Am J Obstet Gynecol 2010;203:115.e1-7.
20. Peipert JF, Zhao Q, Allsworth JE, et al. Continuation and satisfaction of reversible contraception. Obstet Gynecol 2011;117:1105-1113.
21. Trussell J, Lalla AM, Doan QV, Reyes E, Pinto L, Gricar J. Cost effectiveness of contraceptives in the United States. Contraception 2009;79:5-14.
22. Cleland K, Peipert JF, Westhoff C, Spear S, Trussell J. Family planning as a cost-saving preventive health service. New Engl J Med 2011;364:e37.
23. Harper, CC, Rocca C, Darney PD, Thompson KM, Westhoff C, Speidel JJ. Long-acting reversible contraceptive training intervention: Results from a cluster randomized trial on pregnancy outcomes. Obstet Gynecol 2014; 123:106S-107S.